Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$236,479,638
+$61,105,253 QoQ
Shares Held
197,160
+3.4% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
7.26%
of 13F equity value
Holder Rank
#240
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 53%
None 47%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bollard Group LLC holds $279,449,341 across 9 Drug Manufacturers - General names. LLY ranks #1 (84.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
197,160 | $236,479,638 | |
| 2 | MRK |
Merck & Co., Inc.
|
146,931 | $18,880,633 | |
| 3 | JNJ |
Johnson & Johnson
|
60,481 | $15,360,359 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
115,148 | $6,634,827 | |
| 5 | AMGN |
Amgen Inc
|
4,088 | $1,480,346 | |
| 6 | ABBV |
AbbVie Inc.
|
2,222 | $559,144 | |
| 7 | AZN |
Astrazeneca PLC
|
277 | $52,524 | |
| 8 | OGN |
Organon & Co.
|
138 | $1,868 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $236,479,638 | 197,160 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $175,374,385 | 190,672 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $213,023,089 | 198,220 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $158,173,715 | 207,305 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $196,043,220 | 251,489 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $198,336,505 | 240,143 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $185,198,940 | 239,895 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $222,834,286 | 251,523 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $227,780,932 | 251,586 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $195,539,468 | 251,349 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $146,365,382 | 251,090 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $134,708,981 | 250,794 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $117,473,862 | 250,488 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $85,952,874 | 250,285 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $91,363,784 | 249,737 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $83,021,082 | 256,753 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $83,182,179 | 256,553 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $73,324,465 | 256,048 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $70,091,101 | 253,751 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $58,456,805 | 253,005 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $57,765,134 | 251,678 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $51,070,609 | 273,368 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $50,302,163 | 297,928 | Shares | Defined | 2021-02-04 | |
| 2020-09-30 | $44,383,352 | 299,847 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $49,229,208 | 299,849 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $42,585,236 | 306,987 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||